What is Nephros?
Founded in 1997, Nephros has established itself as a critical provider of high-performance liquid purification filters, commonly referred to as ultrafilters. The company operates at the intersection of medical technology and public health, focusing on the removal of biological contaminants such as Legionella, Pseudomonas, viruses, and endotoxins. Its product suite is essential for maintaining sterile water standards in high-risk areas, including hospital showers, sinks, and ice machines, as well as providing vital filtration for hemodialysis machines. By addressing the growing demand for advanced infection control, Nephros occupies a defensive yet essential niche in the medical device landscape, ensuring patient safety through rigorous water quality management.
How much funding has Nephros raised?
Nephros has raised a total of $20.3M across 6 funding rounds:
Stock Offering
$12.6M
Share Placement
$1.3M
Share Placement
$1.2M
Share Placement
$2.9M
Share Placement
$2M
Debt
$350K
Stock Issuance/Offering (2004): $12.6M, investors not publicly disclosed
Share Placement (2009): $1.3M led by Undisclosed
Share Placement (2015): $1.2M, investors not publicly disclosed
Share Placement (2018): $2.9M, investors not publicly disclosed
Share Placement (2019): $2M, investors not publicly disclosed
Debt (2020): $350K with participation from PPP
Key Investors in Nephros
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Nephros?
Looking ahead, the strategic deployment of the $350K capital will likely focus on expanding the commercial reach of Nephros's ultrafiltration portfolio. As healthcare facilities globally prioritize infection prevention, the company is well-positioned to capitalize on the increasing regulatory and safety requirements for water systems in clinical settings. Future growth trajectories will likely involve deepening market penetration within the dialysis sector and exploring new applications for its filtration technology. By maintaining a focus on operational excellence and technological innovation, Nephros is poised to sustain its growth momentum, leveraging its established reputation to secure a larger share of the medical infrastructure market.
See full Nephros company page
